Cargando…
EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA
By profiling enhancers in primary ependymoma tumors, we have recently identified putative oncogenes, molecular targets, and functional pathways. Inhibition of selected targets diminished the proliferation of patient-derived neurospheres and increased survival in mouse models of ependymoma. While enh...
Autores principales: | Okonechnikov, Konstantin, Hübner, Jens-Martin, Chapman, Owen, Chakraborty, Abhijit, Pagadala, Meghana, Bump, Rosalind, Chandran, Sahaana, Kraft, Katerina, Hidalgo, Rocio Acuna, Mundlos, Stefan, Wechsler-Reya, Robert, Juarez, Edwin F, Coufal, Nicole, Levy, Michael, Crawford, John, Pajtler, Kristian, Reid, Derek, Schmitt, Anthony, Carter, Hannah, Ay, Ferhat, Dixon, Jesse, Mesirov, Jill, Pfister, Stefan M, Kool, Marcel, Chavez, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715851/ http://dx.doi.org/10.1093/neuonc/noaa222.145 |
Ejemplares similares
-
EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma
por: Okonechnikov, Konstantin, et al.
Publicado: (2022) -
EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022) -
EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022) -
EPEN-03. ZFTA/C11ORF95 FUSIONS DRIVE SUPRATENTORIAL EPENDYMOMA VIA SHARED ONCOGENIC MECHANISMS
por: Zheng, Tuyu, et al.
Publicado: (2021) -
EPEN-04. Refinement of molecular and clinical characteristics in a cohort of 1,801 ependymomas
por: Pohl, Lara, et al.
Publicado: (2022)